Robert L. Sufit

Neuromusculoskeletal Medicine

259 E Erie St Ste 1900
Lavin Family Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial.

Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial.

Journal: JAMA

Published: November 08, 2025

Gastrocnemius Myofiber Type and Mitochondrial Alterations Associated With Peripheral Artery Disease Severity.

Gastrocnemius Myofiber Type and Mitochondrial Alterations Associated With Peripheral Artery Disease Severity.

Journal: Function (Oxford, England)

Published: June 20, 2025

Telmisartan modulates exercise responses in peripheral artery disease: Analyses of skeletal muscle from the TELEX Trial.

Telmisartan modulates exercise responses in peripheral artery disease: Analyses of skeletal muscle from the TELEX Trial.

Journal: JVS-vascular science

Published: March 20, 2025

The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease.

The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease.

Journal: Vascular medicine (London, England)

Published: September 06, 2024

Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.

Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.

Journal: Nature communications

Published: August 12, 2024

Hepatocyte growth factor for walking performance in peripheral artery disease.

Hepatocyte growth factor for walking performance in peripheral artery disease.

Journal: Journal of vascular surgery

Published: July 30, 2024

Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy.

Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy.

Journal: medRxiv : the preprint server for health sciences

Published: July 01, 2024

Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy.

Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy.

Journal: Scientific reports

Published: April 15, 2024

Cocoa flavanols, Nrf2 activation, and oxidative stress in peripheral artery disease: mechanistic findings in muscle based on outcomes from a randomized trial.

Cocoa flavanols, Nrf2 activation, and oxidative stress in peripheral artery disease: mechanistic findings in muscle based on outcomes from a randomized trial.

Journal: American journal of physiology. Cell physiology

Published: January 08, 2024

Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.

Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial.

Journal: Nature communications

Published: November 23, 2023

Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial.

Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial.

Journal: Journal of the American Heart Association

Published: August 29, 2023

Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials.

Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials.

Journal: Vascular medicine (London, England)

Published: August 25, 2023

Showing 1-12 of 50

Last Updated: 09/26/2026